India's first dengue vaccine arrives with a safety caveat
India's first dengue vaccine, Qdenga, has arrived, but with an important safety caveat. In children never previously infected, the vaccine can mimic a primary dengue infection — offering protection against DENV-1 and DENV-2 but not against DENV-3, and potentially enhancing disease. This underlines the need for careful screening before administration.
Nabka Insight
First dengue vaccine in India plus its serotype-specific caveat — a science-and-health talking point.
Powered by AIKey facts
- Qdenga is India's first dengue vaccine.
- In previously uninfected children it can simulate a primary infection.
- Protects against DENV-1 and DENV-2 but not DENV-3.
Relevant forUPSC · SSC · Railways · State PSC